FTSE 100 reaction as HSBC sees profits drop, Nationwide launches benefits line - Stock market news and latest business and ...

Tempus AI's growth is fueled by data services and acquisitions, despite financial risks. Key Q2 results may shape its path to ...

The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...

Soriot said the industry should help shape pricing reforms before they are imposed by regulators, and backed applying changes ...

Two diabetes drugs could become more affordable for Maryland residents, following a study by the Prescription Drug ...

AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

The FTSE 100 concluded the day with a 0.6% increase, driven by healthcare gains and AstraZeneca's strong profit report.

A formal trade agreement between the US and EU introduces a 15% tariff on most EU exports, including pharmaceuticals, ...

Imfinzi plus chemo cut progression or death risk in early gastric cancer; the FDA's decision is expected late 2025 following breakthrough designation.

Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...

AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 ...